Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001393905-12-000019
Filing Date
2012-01-17
Accepted
2012-01-17 16:27:05
Documents
11
Period of Report
2011-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT trab_10q.htm 10-Q 204960
2 CERTIFICATION trab_ex311.htm EX-31.1 6443
3 CERTIFICATION trab_ex312.htm EX-31.2 6446
4 CERTIFICATION trab_ex321.htm EX-32.1 3996
5 CERTIFICATION trab_ex322.htm EX-32.2 3537
  Complete submission text file 0001393905-12-000019.txt   1160099

Data Files

Seq Description Document Type Size
6 trab-20111130.xml EX-101.INS 72661
7 trab-20111130.xsd EX-101.SCH 11163
8 trab-20111130_cal.xml EX-101.CAL 5562
9 trab-20111130_def.xml EX-101.DEF 49447
10 trab-20111130_lab.xml EX-101.LAB 88839
11 trab-20111130_pre.xml EX-101.PRE 64203
Mailing Address 120 WALL STREET SUITE 2401 NEW YORK NY 10005
Business Address 120 WALL STREET SUITE 2401 NEW YORK NY 10005 866-284-9561
TheraBiogen, Inc. (Filer) CIK: 0001405286 (see all company filings)

EIN.: 980559606 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-53008 | Film No.: 12529902
SIC: 2834 Pharmaceutical Preparations